The major finding in this study is that circulating levels of Gal-9 are elevated in patients with SLE and are correlated with SLE disease activity and could be a discriminator between SLE patients with and without organ damage distinguished by SLCC damage score. This evidence concerns the gene LGALS9 and systemic lupus erythematosus.